Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-09
2009-06-30
Anderson, Rebecca L (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S408000, C544S239000
Reexamination Certificate
active
07553972
ABSTRACT:
The present invention provides benzamide inhibitors of the P2X7receptor of the formula:wherein R1-R3are as defined herein. The compounds of the invention are useful in the treatment of IL-1 mediated disorders, including, without limitation, inflammatory diseases such as osteoarthritis and rheumatoid arthritis; allergies, asthma, COPD, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.
REFERENCES:
patent: 5077409 (1991-12-01), Wissner
patent: 5128351 (1992-07-01), Wissner
patent: 5281571 (1994-01-01), Woodard et al.
patent: 5686061 (1997-11-01), Li
patent: 5773646 (1998-06-01), Chandrakumar
patent: 5939418 (1999-08-01), Quan et al.
patent: 5961376 (1999-10-01), Gottschald
patent: 6001862 (1999-12-01), Maeda
patent: 6030990 (2000-02-01), Maeda
patent: 6147101 (2000-11-01), Maeda
patent: 6180844 (2001-01-01), Fujita
patent: 6187797 (2001-02-01), Pruitt et al.
patent: 6201024 (2001-03-01), Baxter et al.
patent: 6201130 (2001-03-01), Schwab et al.
patent: 6242470 (2001-06-01), Baxter et al.
patent: 6258838 (2001-07-01), Baxter et al.
patent: 6265409 (2001-07-01), Cheshire et al.
patent: 6297239 (2001-10-01), deSolms et al.
patent: 6303659 (2001-10-01), Baxter et al.
patent: 6320078 (2001-11-01), Suzuki et al.
patent: 6335333 (2002-01-01), Schwab et al.
patent: 6451824 (2002-09-01), Thorwart et al.
patent: 6492355 (2002-12-01), Alcaraz et al.
patent: 6653312 (2003-11-01), Auvin et al.
patent: 6720452 (2004-04-01), Alcaraz et al.
patent: 6927219 (2005-08-01), Duplantie
patent: 6974812 (2005-12-01), Dombrowski et al.
patent: 7176202 (2007-02-01), Dombrowski et al.
patent: 2001/0003121 (2001-06-01), Baxter et al.
patent: 2002/0193414 (2002-12-01), Alcaraz et al.
patent: 2003/0013704 (2003-01-01), Alcaraz et al.
patent: 2003/0013721 (2003-01-01), Meghani et al.
patent: 2003/0032807 (2003-02-01), Andree et al.
patent: 2003/0040513 (2003-02-01), Baxter et al.
patent: 2003/0087945 (2003-05-01), Thorwart et al.
patent: 2003/0144293 (2003-07-01), Duplantier
patent: 2003/0149692 (2003-08-01), Mitchell
patent: 2003/0186981 (2003-10-01), Duplantier et al.
patent: 2005/0009900 (2005-01-01), Dombrowski et al.
patent: 2005/0288256 (2005-12-01), Li
patent: 2005/0288288 (2005-12-01), Leonard et al.
patent: 2006/0018904 (2006-01-01), Chung et al.
patent: 2006/0040939 (2006-02-01), Dombroski et al.
patent: 2006/0058302 (2006-03-01), Duplantier et al.
patent: 2006/0211709 (2006-09-01), Buhr et al.
patent: 0138527 (1985-04-01), None
patent: 0881219 (2004-07-01), None
patent: WO-92/11242 (1992-07-01), None
patent: WO-93/04686 (1993-03-01), None
patent: WO-98/43973 (1998-10-01), None
patent: WO-99/29686 (1999-06-01), None
patent: WO-00/35864 (2000-06-01), None
patent: WO-00/71509 (2000-11-01), None
patent: WO 02/094767 (2002-11-01), None
patent: WO 03/042191 (2003-05-01), None
patent: WO-2004/058270 (2004-07-01), None
patent: WO-2004/058731 (2004-07-01), None
patent: WO 2004/099146 (2004-11-01), None
patent: WO 2006/003500 (2006-01-01), None
patent: WO 2006/003517 (2006-01-01), None
Drug Development Research (1996), 37(3), p. 126.
Aranapakam, et al., “5-fluoro-2-methyl-N-[5-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-yl carbonyl)-2-pyridinyl]benzamide (CL-385004) and analogs as orally active arginine vasopressin receptor antagonists”, Bioorganic & Medicinal Chemistry Letters, 1999, pp. 1737-1740, vol. 9 No. 13.
Dayan, et al, Effects of Isoxazole Herbicides on Protoporhyrinogen Oxidase and Porphyrin Physiology, J. Agric. Food Chem., 1997, vol. 45, 967-975.
Gaede, et al, Novel Perfluoroalkyl-Substituted Pyrazoles. 1. Hydroxypyrazoles, J. Heterocyclic Chem., 1993, vol. 30, 49-54.
Hamper, Regioselective Synthesis of 1-Methyl-3-Hydroxy-5-Perfluoroalkykpyrazoles by the addition of Methylhydrazine to Perfluoroalklacetylenic Esters, Journal of Flourine Chemistry, 1990, vol. 48, 123-131.
Hamper, et al, Cyclocondensation of Alkyhydrazines and beta-substituted Acetylenic Esters: Synthesis of 3-Hydroxypyrazoles, J. Org. Chem, 1992, vol. 57, 5680-5686.
Hamper, et al, Synthesis of Chiral Substituted Phenyl(Trifluoromethyl)Pyrazole Herbicides, American Chemical Society, 216th ACS National Meeting, Ab. 290, Boston, MA, Aug. 23-27, 1998.
Hamper, et al, Chiral 3-Aryl-4-halo-5-(trifluoromethyl)pyrazoles , Synthesis and Herbicidal Activity of Enantiomeric Lactate Derivatives of Aryl-Pyrazole Herbicides, ACS Symposium Series, 2000, 746 (Asymmetric Fluororganic Chemistry) 272-281.
Prosch, et al, JV 485: A New Herbicide for Pre-Emergence Broad Spectrum Weed Control in Winter Wheat, The 1997 Brighton Crop Protection Conference—Weeds, 2-5, 45-50.
Zhou, et al, Synthesis and Herbicidal Activities of 3-(Substituted phenyl)isoxazole Derivatives, Chinese Chemical Letters, 2003, vol. 14, No. 9, 897-900.
Dombrowski Mark A.
Duplantier Allen J.
Subramanyam Chakrapani
Anderson Rebecca L
Havlin Robert
Lappin Julie M.
Pfizer Inc.
LandOfFree
Benzamide inhibitors of the P2X 7 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzamide inhibitors of the P2X 7 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzamide inhibitors of the P2X 7 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4139640